Huntsman Ronald Kirk 4
4 · Vivos Therapeutics, Inc. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2023-06-15$0.50/sh+21$11→ 57,521 total - Purchase
Common Stock
2023-06-16$0.54/sh+10,000$5,400→ 67,521 total - Purchase
Common Stock
2023-06-16$0.53/sh+5,000$2,650→ 72,521 total
Holdings
- 1,740,000(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.